Mancini, M.; Monaldi, C.; De Santis, S.; Rondoni, M.; Papayannidis, C.; Sartor, C.; Curti, A.; Bruno, S.; Cavo, M.; Soverini, S.
Combined Inhibition of Polo-Like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells. Cancers 2022, 14, 738.
https://doi.org/10.3390/cancers14030738
AMA Style
Mancini M, Monaldi C, De Santis S, Rondoni M, Papayannidis C, Sartor C, Curti A, Bruno S, Cavo M, Soverini S.
Combined Inhibition of Polo-Like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells. Cancers. 2022; 14(3):738.
https://doi.org/10.3390/cancers14030738
Chicago/Turabian Style
Mancini, Manuela, Cecilia Monaldi, Sara De Santis, Michela Rondoni, Cristina Papayannidis, Chiara Sartor, Antonio Curti, Samantha Bruno, Michele Cavo, and Simona Soverini.
2022. "Combined Inhibition of Polo-Like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells" Cancers 14, no. 3: 738.
https://doi.org/10.3390/cancers14030738
APA Style
Mancini, M., Monaldi, C., De Santis, S., Rondoni, M., Papayannidis, C., Sartor, C., Curti, A., Bruno, S., Cavo, M., & Soverini, S.
(2022). Combined Inhibition of Polo-Like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells. Cancers, 14(3), 738.
https://doi.org/10.3390/cancers14030738